Clinical Trial Update: The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liraglutide for body weight reduction in obese subjects without diabetes. The study's results were completed and posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2010-10-28